brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
366 |
4. Check minimum number of eventsNone |
366 |
5. Include endpointsNone |
366 |
6. Filter based on genotype QC (FinnGen only) |
334 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum oropharyngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other parts of oropharynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2025 | 1071 | 939 |
| Only index persons | 1865 | 1002 | 863 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 51.53 | 52.28 | 50.52 |
| Only index persons | 50.66 | 51.48 | 49.72 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 334 | 194 | 140 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.06 |
| Median age at first event (years) | 54.33 | 50.80 | 59.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 348
- Matched controls
- 3480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
+∞
307.7
331
*
ENA10
NOMESCO Finland
Biopsy of pharynx
142.0
47.1
49
*
UJC01
NOMESCO Finland
Scopy of lower throat
27.9
24.5
33
13
EHA10
NOMESCO Finland
Biopsy of palate
64.2
21.2
24
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.5
17.0
45
112
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
19.1
16.7
25
14
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
167.2
15.6
16
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
6.5
14.9
25
41
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
20.2
14.4
21
11
EHB00
NOMESCO Finland
Excision of lesion of palate
33.4
12.7
16
5
R07.0
ICD-10 Finland
Pain in throat
3.6
12.4
43
130
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
11.1
11.9
22
21
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.7
11.0
37
109
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
20.8
9.9
14
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.2
9.4
40
137
G47.3
ICD-10 Finland
Sleep apnoea
2.2
9.2
101
551
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.4
9.1
18
20
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
51.3
8.7
10
*
WX402
NOMESCO Finland
General anaesthesia
2.1
8.6
96
524
R21
ICPC
Throat symptom/complaint
2.2
8.6
94
509
J39.2
ICD-10 Finland
Other diseases of pharynx
10.4
8.1
15
15
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
8.0
146
947
JDB10
NOMESCO Finland
Percutaneous gastrostomy
11.2
7.9
14
13
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
46.0
7.7
9
*
WF002
NOMESCO Finland
Radical radiotherapy
3.5
7.7
27
82
GBB00
NOMESCO Finland
Tracheostomy
12.2
7.6
13
11
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
81.8
7.4
8
*
2106A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
21068
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
J35.0
ICD-10 Finland
Chronic tonsillitis
3.4
7.3
27
85
EMA10
NOMESCO Finland
Biopsy of tonsil
20.5
7.2
10
5
ZXE00
NOMESCO Finland
One hour or less
1.9
7.0
142
944
130
Kela drug reimbursment
Malignant tumour
2.6
7.0
41
168
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
7.8
7.0
15
20
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
14.1
6.9
11
8
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
14.1
6.9
11
8
EMB10
NOMESCO Finland
Tonsillectomy
3.2
6.8
28
94
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
23.0
6.7
9
*
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
71.1
6.4
7
*
Z01.2
ICD-10 Finland
Dental examination
1.8
6.3
172
1240
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
6.1
132
887
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
192
1353
1.93
8.31
6.0
5.1
35.78
35.96
g/l
0.16
184
1289
201
1503
1.80
6.60
2.9
2.8
—
—
estimate
—
0
0
285
2382
2.09
6.57
9.5
8.4
78.61
78.99
u/l
0.06
275
2249
233
1835
1.82
6.29
6.3
5.3
6.62
6.58
mmol/l
0.13
222
1722
229
1797
1.80
6.22
10.2
10.3
4.23
4.04
e9/l
0.70
193
1574
285
2410
2.01
5.94
5.1
4.3
14.72
14.72
pmol/l
0.01
264
2206
201
1536
1.73
5.82
9.3
7.7
1.21
1.21
mmol/l
0.37
176
1336
276
2320
1.92
5.70
4.9
4.4
11.51
11.29
mm/h
0.09
259
2158
41
186
2.37
5.65
3.8
4.1
4.69
4.64
pmol/l
0.11
35
165
188
1418
1.71
5.64
18.0
11.7
1.27
1.20
inr
0.92
156
1169
147
1065
1.66
4.94
4.0
3.5
2.35
2.35
mmol/l
0.10
135
972
331
3025
2.93
4.86
23.1
15.9
21.22
23.54
mg/l
0.81
297
2487
57
316
1.96
4.73
2.5
2.5
38.06
33.48
u/l
0.26
47
260
176
1348
1.62
4.66
2.3
2.1
92.87
96.65
pmol/l
0.61
92
707
94
618
1.71
4.49
1.8
1.6
—
—
—
0
0
75
470
1.76
4.23
1.9
1.9
29.75
29.19
s
0.42
70
460
178
1395
1.56
4.09
8.2
7.0
1.22
1.21
mmol/l
0.30
169
1293
103
712
1.63
4.02
1.9
1.7
1.95
1.27
mg/l
0.57
81
575
315
2857
2.08
4.02
6.5
5.3
1.91
1.88
mu/l
0.13
299
2631
20
78
2.66
3.79
1.5
1.2
—
—
—
0
0
138
1038
1.55
3.71
3.3
3.3
21.04
111.56
e6/l
0.80
106
779
148
1134
1.53
3.64
3.8
3.3
28.68
32.43
u/l
1.00
139
1078
46
260
1.89
3.61
5.1
2.6
66.82
66.77
g/l
0.02
46
243
176
1402
1.52
3.60
2.4
2.5
76.44
76.33
nmol/l
0.02
156
1267
330
3074
2.42
3.48
25.7
18.2
139.53
139.77
mmol/l
1.05
325
3019
121
897
1.53
3.43
3.3
3.1
0.59
0.36
e6/l
0.45
86
635
318
2924
2.02
3.42
20.2
15.1
83.01
82.97
ml/min/173m2
0.01
297
2691
33
169
2.05
3.42
3.9
3.1
1.71
1.74
mmol/l
0.01
27
131
330
3077
2.40
3.42
26.1
18.3
3.93
3.97
mmol/l
2.24
324
3017
109
790
1.55
3.42
2.7
2.4
—
—
—
0
0
62
397
1.68
3.21
1.9
1.9
—
—
—
0
0
230
1968
1.50
3.13
3.7
3.2
—
—
—
0
0
77
525
1.60
3.11
2.2
2.0
—
—
—
0
0
59
379
1.67
3.01
1.9
1.9
—
—
—
0
0
125
955
1.48
3.00
2.2
2.2
170.14
261.06
u/l
0.65
114
911
85
607
1.53
2.79
4.0
3.6
125.34
330.17
ng/l
0.97
63
453
64
431
1.59
2.71
7.5
7.6
103.70
104.21
mmol/l
0.34
64
431
75
526
1.54
2.67
3.5
2.4
14.26
13.46
umol/l
0.38
67
490
23
114
2.09
2.63
1.7
1.5
7.16
11.21
u/ml
—
5
18
245
2162
1.45
2.55
3.8
3.3
50.92
48.36
u/l
0.22
236
2054
8
21
3.87
2.47
1.3
1.4
—
—
—
0
0
8
21
3.87
2.47
1.3
1.4
—
—
—
0
0
117
912
1.43
2.44
3.6
3.2
1129.16
1192.42
ng/l
0.06
102
763
32
184
1.81
2.42
9.2
11.2
15.89
15.77
%
0.10
32
177
18
84
2.21
2.39
2.1
2.0
4.50
5.70
iu/l
—
8
36
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
78
2.24
2.35
2.4
2.6
0.29
0.37
iu/ml
—
8
41
19
92
2.13
2.32
1.3
1.2
—
—
—
0
0
179
1515
1.37
2.26
3.9
3.0
135.52
120.56
ug/l
0.30
164
1419
68
484
1.50
2.25
3.6
2.4
2.34
2.29
g/l
0.36
61
450
11
41
2.74
2.22
1.8
1.4
100.57
0.52
nmol/l
0.47
11
36
37
229
1.69
2.19
1.9
2.5
4.79
5.90
ug/l
0.25
27
210
7
19
3.74
2.16
1.3
1.3
—
—
—
0
0
7
19
3.74
2.16
1.3
1.3
—
—
—
0
0
194
1671
1.36
2.15
4.5
3.7
0.00
0.00
estimate
-0.00
50
340
334
3193
2.14
2.14
14.9
12.1
27.60
26.67
u/l
0.43
325
3108
306
2856
1.59
2.13
6.9
6.2
39.66
39.08
mmol/mol
0.54
287
2692
36
224
1.68
2.10
1.2
1.2
84.14
141.35
u/ml
—
7
79
19
96
2.04
2.09
3.5
2.5
1.34
1.48
mg/l
0.39
19
85
195
1686
1.36
2.09
4.5
3.7
0.00
0.00
estimate
-0.00
51
346
69
501
1.47
2.07
1.9
1.6
1406.91
1219.05
nmol/l
0.77
46
378
21
111
1.95
2.05
3.3
2.9
—
—
—
0
0
80
602
1.43
1.99
3.6
2.8
2.44
2.45
mmol/l
0.29
71
543
196
1703
1.35
1.99
4.7
3.7
0.00
0.93
estimate
0.50
48
323
18
91
2.03
1.99
1.0
1.1
—
—
—
0
0
159
1342
1.34
1.95
2.0
2.0
1.53
1.36
mmol/l
1.11
130
1139
5
11
4.59
1.95
2.2
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.59
1.95
1.0
2.0
152.60
136.64
%
—
5
11
24
137
1.81
1.88
3.2
1.8
4.08
3.68
g/l
0.38
24
128
24
137
1.81
1.88
3.2
1.8
7.00
7.42
g/l
0.70
24
128
24
137
1.81
1.88
3.2
1.8
4.12
4.26
g/l
0.36
24
128
18
93
1.99
1.88
1.0
1.1
—
—
—
0
0
127
1041
1.35
1.88
3.0
2.6
58.66
65.99
u/l
0.54
117
964
46
313
1.54
1.88
8.1
10.6
122.26
121.03
g/l
0.15
46
307
6
17
3.57
1.84
5.2
2.7
0.50
0.82
index
—
6
17
143
1201
1.32
1.78
5.2
3.8
19.63
38.59
ng/l
3.05
95
833
35
227
1.60
1.76
1.8
1.6
—
—
—
0
0
37
244
1.58
1.74
1.4
1.5
—
—
—
0
0
61
449
1.43
1.71
3.7
2.4
23.50
23.35
%
0.03
55
423
310
2930
1.53
1.71
5.7
5.0
6.03
5.90
mmol/l
0.91
287
2715
16
83
1.97
1.67
4.6
3.1
4.20
1.84
index
—
10
50
68
513
1.40
1.67
3.1
3.1
2.15
2.25
e6/l
0.03
32
234
7
25
2.84
1.66
1.1
1.3
—
—
—
0
0
10
42
2.42
1.63
1.0
1.2
—
—
—
0
0
46
324
1.48
1.62
4.1
3.1
—
—
—
0
0
113
930
1.32
1.59
3.7
3.1
0.00
0.10
estimate
0.55
42
282
22
130
1.74
1.57
2.9
1.9
2.48
3.04
g/l
2.48
22
121
47
337
1.46
1.52
4.8
6.9
—
—
—
0
0
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
18
101
1.82
1.52
2.7
3.2
9.04
2.32
ratio
—
9
53
6
21
2.89
1.51
1.5
1.7
—
—
—
0
0
49
357
1.43
1.46
8.3
9.9
0.55
0.83
mmol/l
0.20
49
313
19
110
1.77
1.46
2.7
3.4
56.94
103.26
mg/l
0.39
14
94
17
95
1.83
1.46
1.4
1.3
—
—
—
0
0
19
111
1.75
1.42
2.2
1.9
—
—
—
0
0
338
3283
2.03
1.41
33.3
24.0
4.47
4.50
e12/l
0.43
331
3222
25
159
1.62
1.39
1.4
1.3
—
—
—
0
0
6
23
2.64
1.37
1.0
1.8
—
—
—
0
0
44
319
1.43
1.36
2.5
4.7
3.92
21.67
ug/l
0.71
33
257
33
226
1.51
1.35
2.2
2.0
—
—
—
0
0
72
569
1.33
1.33
3.0
2.9
0.66
0.87
e6/l
0.34
36
290
24
153
1.61
1.33
1.3
1.3
27.32
22.10
iu/l
0.27
19
131
49
366
1.39
1.29
8.5
9.6
5.14
5.16
kpa
0.06
49
355
49
366
1.39
1.29
8.5
9.6
13.72
12.24
kpa
0.87
49
356
28
187
1.54
1.28
2.0
1.7
—
—
—
0
0
75
601
1.32
1.26
1.7
1.7
451.05
22674871.43
pmol/l
0.50
56
516
111
938
1.27
1.25
4.5
3.9
0.00
0.00
estimate
-0.00
48
324
52
396
1.37
1.23
2.5
2.2
—
—
—
0
0
21
133
1.62
1.20
4.6
8.2
2.03
1.54
%
0.76
21
124
97
812
1.27
1.17
3.1
2.9
373.11
343.56
umol/l
1.90
87
725
119
1023
1.25
1.15
5.3
4.1
3.40
9.82
mg/mmol
4.42
75
633
0
36
0.00
1.14
0.0
1.7
—
—
—
0
0
8
40
2.02
1.12
1.0
1.7
—
—
—
0
0
47
358
1.36
1.11
2.4
2.1
—
—
—
0
0
125
1084
1.24
1.11
4.1
3.3
7.39
7.87
mmol/l
0.61
105
917
144
1271
1.23
1.08
4.5
3.6
0.05
0.01
estimate
0.40
42
287
300
2867
1.34
1.07
4.7
4.2
1.37
1.27
mmol/l
1.57
278
2652
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
24
163
1.51
1.05
1.7
1.5
0.47
0.31
mg/l
—
10
67
312
3002
1.38
1.04
5.6
5.0
1.40
1.47
mmol/l
2.03
291
2794
35
259
1.39
1.00
1.9
2.7
0.14
0.19
e6/l
0.34
35
247
26
184
1.45
0.94
1.7
1.9
—
—
—
0
0
7
37
1.91
0.94
1.0
1.2
—
—
—
0
0
7
37
1.91
0.94
1.0
1.3
—
—
—
0
0
91
777
1.23
0.92
1.4
1.3
0.56
1.46
u/ml
1.83
22
204
6
29
2.09
0.89
1.0
1.3
0.37
1.27
promille
—
6
22
312
3015
1.34
0.88
5.7
5.1
4.60
4.64
mmol/l
0.35
296
2826
8
46
1.76
0.83
1.9
1.4
—
—
—
0
0
10
58
1.75
0.80
2.0
1.4
—
231.43
—
0
7
15
98
1.55
0.80
2.4
1.9
—
—
—
0
0
8
48
1.68
0.79
1.4
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.9
—
7.03
—
0
27
6
34
1.78
0.76
4.3
3.9
2.35
2.90
nmol/l
—
6
34
10
59
1.72
0.76
1.2
1.4
—
—
—
0
0
10
59
1.72
0.76
1.2
1.4
—
—
—
0
0
5
24
2.10
0.75
1.4
3.9
287.60
1035.67
mg
—
5
24
13
84
1.57
0.73
1.4
1.5
—
—
—
0
0
9
57
1.59
0.71
1.0
1.9
—
—
—
0
0
314
3052
1.30
0.71
6.5
5.7
2.75
2.73
mmol/l
0.20
294
2852
31
240
1.32
0.70
2.6
2.7
66.00
67.22
ml/min/173m2
0.05
11
102
12
77
1.58
0.69
1.1
1.4
—
—
—
0
0
102
907
1.18
0.67
1.8
1.7
20.09
20.53
nmol/l
0.11
90
774
17
120
1.44
0.66
1.9
1.5
—
—
—
0
0
73
632
1.20
0.65
1.3
1.3
17.60
31.06
iu/ml
1.02
14
193
18
129
1.42
0.65
2.3
1.9
2.57
4.39
ug/l
0.30
13
114
34
272
1.28
0.62
1.9
2.4
10.83
13.42
nmol/l
0.96
27
252
8
49
1.65
0.62
1.4
1.5
—
—
—
0
0
8
49
1.65
0.62
1.4
1.5
—
—
—
0
0
8
49
1.65
0.62
1.4
1.5
—
—
—
0
0
8
50
1.61
0.61
1.4
1.5
—
—
—
0
0
8
53
1.52
0.59
5.7
3.1
7.37
9.63
pmol/l
—
8
53
16
115
1.41
0.57
1.5
1.4
—
—
—
0
0
10
65
1.55
0.56
2.3
3.8
—
3908.86
—
0
7
15
108
1.41
0.54
2.3
1.7
—
—
—
0
0
6
40
1.51
0.52
1.0
1.7
—
—
—
0
0
13
92
1.43
0.51
1.0
1.8
—
—
—
0
0
7
46
1.53
0.48
1.0
1.0
—
—
—
0
0
12
85
1.43
0.47
1.5
1.7
—
—
—
0
0
23
183
1.28
0.46
1.4
1.6
819.70
974.44
mu/l
0.62
18
153
7
49
1.44
0.46
2.3
1.8
—
—
—
0
0
7
49
1.44
0.46
1.3
1.4
—
—
—
0
0
7
50
1.41
0.45
1.4
1.5
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
5
33
1.52
0.41
2.4
2.3
—
—
—
0
0
15
115
1.32
0.39
1.5
1.5
351.21
257.66
miu/ml
—
6
57
9
66
1.37
0.38
1.0
1.6
—
—
—
0
0
262
2544
1.12
0.38
26.4
20.3
332.47
332.40
g/l
0.04
262
2535
20
161
1.26
0.38
1.5
1.5
—
—
—
0
0
6
41
1.47
0.36
1.3
1.3
—
—
—
0
0
14
108
1.31
0.36
1.6
1.1
0.89
0.91
g/l
0.12
14
108
13
100
1.31
0.34
1.5
1.1
0.50
0.73
ratio
—
5
15
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
6
87
0.68
0.33
1.8
2.0
119.50
220.96
pmol/l
—
6
81
45
399
1.15
0.33
5.4
4.6
30.32
31.58
%
0.29
34
266
87
805
1.11
0.33
2.7
2.1
2.52
2.86
mg/l
1.08
74
697
70
760
0.90
0.30
5.1
4.4
21.81
22.11
%
0.06
37
360
14
111
1.27
0.30
1.2
1.4
—
—
—
0
0
11
85
1.30
0.28
1.2
1.2
—
50.69
—
0
12
64
588
1.11
0.28
1.3
1.3
13.94
8.02
u/ml
0.28
24
223
8
63
1.28
0.28
1.0
1.8
—
—
—
0
0
9
75
1.21
0.25
1.9
1.8
—
—
—
0
0
9
76
1.19
0.25
1.4
1.8
—
—
—
0
0
5
38
1.32
0.23
1.4
2.8
108.00
105.58
mmol/l
—
5
38
5
38
1.32
0.23
1.4
2.8
1.21
1.20
mmol/l
—
5
38
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
12
97
1.25
0.23
1.4
1.5
—
—
—
0
0
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
10
79
1.27
0.22
1.0
1.7
—
—
—
0
0
13
107
1.22
0.22
1.5
1.1
1.58
1.55
g/l
0.24
13
107
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
9.64
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1635.08
—
0
12
21
183
1.16
0.20
7.1
9.4
26.02
24.79
mmol/l
0.66
21
175
10
80
1.26
0.20
1.0
1.4
—
—
—
0
0
13
108
1.21
0.20
1.2
1.3
—
2.48
—
0
6
6
51
1.18
0.19
1.0
1.8
—
—
—
0
0
11
90
1.23
0.19
1.1
1.7
—
—
—
0
0
15
129
1.17
0.17
2.9
2.3
350.35
5464.24
u/l
—
6
48
19
169
1.13
0.15
1.1
1.0
—
—
—
0
0
99
954
1.05
0.14
5.8
5.1
1.71
2.12
ug/l
0.65
86
859
78
748
1.06
0.13
4.5
3.7
1.02
1.02
kg/l
0.17
53
494
5
46
1.09
0.09
2.4
3.7
—
—
—
0
0
53
508
1.05
0.09
1.4
1.5
—
—
—
0
0
19
175
1.09
0.08
2.6
2.5
0.73
0.61
%
0.72
19
175
7
65
1.08
0.08
1.4
1.6
49.11
50.94
ug/l
—
7
65
8
78
1.03
0.07
1.4
1.2
—
—
—
0
0
14
153
0.91
0.07
5.4
3.1
1.02
1.02
ratio
0.15
14
145
9
85
1.06
0.07
1.0
1.2
—
9.47
—
0
9
8
93
0.86
0.07
1.0
1.3
—
—
—
0
0
19
177
1.08
0.06
2.9
2.6
1.44
1.29
%
0.24
19
177
11
104
1.06
0.01
1.2
1.3
—
2.52
—
0
16
10
102
0.98
0.00
1.2
1.6
—
—
—
0
0
26
261
1.00
0.00
1.7
1.9
3.31
3.52
mmol/l
0.47
21
200
12
117
1.03
0.00
1.4
2.0
45.00
41.47
nmol/l
0.27
12
111
36
357
1.01
0.00
2.5
2.0
3.44
3.48
ratio
0.07
30
296
10
104
0.96
0.00
1.3
1.4
—
—
—
0
0
57
574
0.99
0.00
3.2
3.1
0.75
0.76
ug/l
0.03
38
353
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
33.20
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
13
130
1.00
-0.00
1.2
1.5
—
—
—
0
0
8
82
0.98
-0.00
1.9
1.4
—
—
—
0
0
6
63
0.95
-0.00
3.3
4.4
18.33
26.27
mg/l
—
6
44
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_OROPHA_OTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_OROPHA_OTHER | 1.256 [0.99, 1.6] | 0.063 |
| Birth year | 0.996 [0.99, 1.01] | 0.452 |
During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 834 females with CD2_BENIGN_OROPHA_OTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_OROPHA_OTHER | 1.677 [1.28, 2.2] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 733 males with CD2_BENIGN_OROPHA_OTHER died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_OROPHA_OTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.14% | 0.328% |
| 5 | 0.857% | 1.893% |
| 10 | 2.044% | 4.924% |
| 15 | 3.593% | 9.149% |
| 20 | 6.503% | 14.734% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OROPHA_OTHER – Benign neoplasm: Other parts of oropharynx
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data